Facebook
Twitter
LinkedIn
ForwardNephrology Symposium, Seventh Annual
Many diseases affect kidney function. The proper screening of chronic kidney disease and end stage renal disease in patients is crucial. Physicians need to recognize the significance of minor changes in the serum creatinine, which translates to poor outcomes. During this symposium physicians learn about the key discoveries driving clinical trials
Complete details at NephrologySymposium.BaptistHealth.net
Target Audience
Nephrologists, Emergency Medicine Physicians, Family Medicine Physicians, Internists, Hospitalists, Cardiologists, Endocrinologists, Nurses, Respiratory Therapists and other interested healthcare professionals.
Learning Objectives
- Explain key discoveries driving current clinical trials.
- Describe the importance and the strategies when identifying clinically relevant targets.
- Discuss recent advances in diagnosis of genetic disorders.
- Identify case-based examples of how a genetic diagnosis can be used in the clinic. Summarize the guidelines for screening and management of diabetic kidney disease (DKD).
- Summarize the guidelines for screening and management of diabetic kidney disease (DKD).
- Explain the contribution of blood pressure control with different agents on DKD development and progression.
- Describe how new biomarkers can help to stratify patients.
- Summarize the contribution of different hypoglycemia agents on DKD development and progression.
- Identify and diagnose AKI syndromes in critically ill patients.
- Implement treatment plans for the AKI patient.
- Examine novel treatments being investigated.
7:30 a.m. Breakfast and Registration
7:50 a.m. Welcome and Introductions
James Loewenherz, M.D.
7:55 a.m. International Welcome and Introductions
Galed Hakim, M.D.
8:00 a.m. Podocyte targets for the practicing nephrologists
Alessia Fornoni, M.D., Ph.D.
8:50 a.m. Genetics in Clinical Nephrology
Jai Radhakrishnan, M.D., M.S.
9:40 a.m. Questions and Answers
10:00 a.m. Break and Exhibits
10:20 a.m. Diabetes and Kidney Disease
Alessia Fornoni, M.D., M.S.
11:00 a.m. Acute Kidney Injury (AKI) in Critically Ill Patients
Jai Radhakrishnan, M.D., M.S.
11:50 a.m. Questions and Answers
12:20 p.m. Adjourn
Parking: The special-event parking area will be open next to the conference center. The entrance closest to 5 MCVI is located on the south side of the campus. Approach from SW 94 Street (accessible from SW 87 Avenue). At the first Baptist Hospital sign, turn right and make an immediate left. Look for special
event parking on the right.
Alessia Fornoni, M.D., Ph.D.
Professor of Medicine
Chief, Katz Family Division of Nephrology and Hypertension
Director, Peggy and Harold Katz Family Drug Discovery Center
University of Miami
Miami, Florida
Alessia Fornoni, M.D., Ph.D., indicated that she has relevant financial relationships with commercial interest companies. She will not include off-label or unapproved product usage in her presentation(s) or discussion(s).
Grant/Research Support: Roche, BI, NIH
Consultant: Variant Pharmaceutical, Ono, Pfeizer, BI, Astra-Zeneca, Roche, Merck and Johnson and Johnson.
Stock Shareholder: Variant Pharmaceuticals
Jai Radhakrishnan, M.D., M.S.
Professor of Medicine, Columbia University
Clinical Chief, Division of Nephrology, NY Presbyterian Hospital
New York, New York
Jai Radhakrishnan, M.D., M.S., has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 4 credit hours by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants. CE Broker #20-634854.
Approved for a total of 4 contact hours by the Florida State Board of Nursing CE Broker Provider #50-182.
Available Credit
- 4.00 AMA PRA Category 1 Credit™
- 4.00 General certificate of attendance
- 4.00 Nurse Practitioners
- 4.00 Florida Board of Nursing
- 4.00 Florida Board of Respiratory Therapy
Registrations will be accepted Onsite
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.